These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 24887283)
21. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. Kem WR; Mahnir VM; Papke RL; Lingle CJ J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967 [TBL] [Abstract][Full Text] [Related]
22. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. de Fiebre CM; Meyer EM; Henry JC; Muraskin SI; Kem WR; Papke RL Mol Pharmacol; 1995 Jan; 47(1):164-71. PubMed ID: 7838125 [TBL] [Abstract][Full Text] [Related]
23. Blockade of neuronal facilitatory nicotinic receptors containing alpha 3 beta 2 subunits contribute to tetanic fade in the rat isolated diaphragm. Faria M; Oliveira L; Timóteo MA; Lobo MG; Correia-De-Sá P Synapse; 2003 Aug; 49(2):77-88. PubMed ID: 12740863 [TBL] [Abstract][Full Text] [Related]
24. Resistance to D-tubocurarine of the rat diaphragm as compared to a limb muscle: influence of quantal transmitter release and nicotinic acetylcholine receptors. Nguyen-Huu T; Molgó J; Servent D; Duvaldestin P Anesthesiology; 2009 May; 110(5):1011-5. PubMed ID: 19352164 [TBL] [Abstract][Full Text] [Related]
25. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels. Lukas RJ; Audhya T; Goldstein G; Lucero L Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215 [TBL] [Abstract][Full Text] [Related]
26. Stability of cyclic imine toxins: interconversion of pinnatoxin amino ketone and pinnatoxin A in aqueous media. Jackson JJ; Stivala CE; Iorga BI; Molgó J; Zakarian A J Org Chem; 2012 Nov; 77(22):10435-40. PubMed ID: 23116445 [TBL] [Abstract][Full Text] [Related]
27. Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle. Zamudio F; Wolf KM; Martin BM; Possani LD; Chiappinelli VA Biochemistry; 1996 Jun; 35(24):7910-6. PubMed ID: 8672493 [TBL] [Abstract][Full Text] [Related]
28. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro. Mousavi M; Hellström-Lindahl E Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588 [TBL] [Abstract][Full Text] [Related]
29. Pudendal motoneurons of the rat located in separated spinal nuclei possess nicotinic acetylcholine receptors having distinct pharmacological profiles. Ogier R; Tribollet E; Bertrand D; Raggenbass M Eur J Neurosci; 2008 Sep; 28(5):924-30. PubMed ID: 18691331 [TBL] [Abstract][Full Text] [Related]
30. Diazaspirocyclic compounds as selective ligands for the α4β2 nicotinic acetylcholine receptor. Strachan JP; Farias JJ; Zhang J; Caldwell WS; Bhatti BS Bioorg Med Chem Lett; 2012 Aug; 22(15):5089-92. PubMed ID: 22749278 [TBL] [Abstract][Full Text] [Related]
31. Effect of Nitrate, Ammonium and Urea on Growth and Pinnatoxin G Production of Vulcanodinium rugosum. Abadie E; Kaci L; Berteaux T; Hess P; Sechet V; Masseret E; Rolland JL; Laabir M Mar Drugs; 2015 Sep; 13(9):5642-56. PubMed ID: 26404325 [TBL] [Abstract][Full Text] [Related]
32. The non-competitive acetylcholinesterase inhibitor APS12-2 is a potent antagonist of skeletal muscle nicotinic acetylcholine receptors. Grandič M; Aráoz R; Molgó J; Turk T; Sepčić K; Benoit E; Frangež R Toxicol Appl Pharmacol; 2012 Dec; 265(2):221-8. PubMed ID: 23046821 [TBL] [Abstract][Full Text] [Related]
33. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. Meyer EM; Tay ET; Zoltewicz JA; Meyers C; King MA; Papke RL; De Fiebre CM J Pharmacol Exp Ther; 1998 Mar; 284(3):1026-32. PubMed ID: 9495863 [TBL] [Abstract][Full Text] [Related]
34. Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro. Seeger T; Eichhorn M; Lindner M; Niessen KV; Tattersall JE; Timperley CM; Bird M; Green AC; Thiermann H; Worek F Toxicology; 2012 Apr; 294(2-3):80-4. PubMed ID: 22349640 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687 [TBL] [Abstract][Full Text] [Related]
36. Structure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester. Bergmeier SC; Ismail KA; Arason KM; McKay S; Bryant DL; McKay DB Bioorg Med Chem Lett; 2004 Jul; 14(14):3739-42. PubMed ID: 15203153 [TBL] [Abstract][Full Text] [Related]
37. A-186253, a specific antagonist of the alpha 4 beta 2 nAChRs: its properties and potential to study brain nicotinic acetylcholine receptors. Itier V; Schönbächler R; Tribollet E; Honer M; Prinz K; Marguerat A; Bertrand S; Bunnelle WH; Schubiger PA; Meyer MD; Sullivan JP; Bertrand D; Westera G Neuropharmacology; 2004 Sep; 47(4):538-57. PubMed ID: 15380372 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Tsuneki H; Kimura I; Dezaki K; Kimura M; Sala C; Fumagalli G Neurosci Lett; 1995 Aug; 196(1-2):13-6. PubMed ID: 7501241 [TBL] [Abstract][Full Text] [Related]
39. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy. Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799 [TBL] [Abstract][Full Text] [Related]